IDEAS
发表于 2025-3-28 17:01:56
Radiobiology of the Liveration-induced liver disease (RILD) remains a major limitation of RT. The pathophysiology, diagnosis, and treatment of RILD are discussed in this chapter. Classic RILD manifests with hepatomegaly, anicteric ascites, and thrombocytopenia, and alkaline phosphatase elevated out of proportion to other li
易于出错
发表于 2025-3-28 21:31:41
http://reply.papertrans.cn/83/8210/820905/820905_42.png
钝剑
发表于 2025-3-28 23:06:30
http://reply.papertrans.cn/83/8210/820905/820905_43.png
defeatist
发表于 2025-3-29 06:31:01
Antiviral Therapy in Liver Cancerction, respectively. Antiviral therapy using nucleos(t)ide analogs (NA) reduces HCC occurrence and recurrence in HBV-related HCC. NA therapy also improves overall survival by preventing liver function deterioration and decompensation. Indefinite antiviral therapy is recommended for most patients wit
FLIC
发表于 2025-3-29 09:53:58
http://reply.papertrans.cn/83/8210/820905/820905_45.png
发誓放弃
发表于 2025-3-29 14:58:20
http://reply.papertrans.cn/83/8210/820905/820905_46.png
反应
发表于 2025-3-29 18:54:08
Image-Guided Radiotherapydoses of RT safely while respecting the radiation dose limits of numerous normal tissues in the upper abdomen, including the liver itself. Challenges to the routine use of RT to treat hepatic malignancies include the low whole liver tolerance to RT and the proximity of liver tumors to other organs a
爱好
发表于 2025-3-29 21:39:17
Particle Beam Radiotherapyf HCC by particle therapy is expected to be 85–90% at 3 years and 80–90% at 5 years. Overall survival rate is expected to be 55–65% at 2 years and 20–50% at 5 years. The prognostic factors for survival considered are hepatic function and number and size of tumors..Adverse events due to particle ther
无法破译
发表于 2025-3-30 00:19:45
http://reply.papertrans.cn/83/8210/820905/820905_49.png
Dislocation
发表于 2025-3-30 04:59:27
http://reply.papertrans.cn/83/8210/820905/820905_50.png